COMMUNIQUÉS West-GlobeNewswire
-
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations
09/03/2026 -
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
10/03/2026 -
Nebu Ease Portable Nebulizer Claims Evaluated: 2026 Consumer Research Report on Mesh Nebulizer Technology, Respiratory Comfort Features, and What Buyers Should Verify
10/03/2026 -
Update: Ipsen retire volontairement Tazverik® (tazemetostat) dans le traitement du lymphome folliculaire et du sarcome épithélioïde
09/03/2026 -
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
09/03/2026 -
The Great Give Back brings community together in support of Royal Columbian Hospital
09/03/2026 -
VisiFlora Gut-Eye Vision Support Claims Examined: 2026 Consumer Report on the 22-Ingredient Formula, Gut-Eye Axis Research, and What Adults Researching Vision Supplements Should Verify
09/03/2026 -
Choice Healthcare Services Announces Expansion of Children’s Choice Pediatric Dentistry Locations in California
09/03/2026 -
FocusMax Cognitive Support Claims Evaluated: Latest 2026 Consumer Research Report on FocusMax Ingredients, Proprietary Blend Dosing, and Cognitive Supplement Research
09/03/2026 -
MemoTril Consumer Concerns Under Investigation: Critiquing The Memo Tril Claims
09/03/2026 -
Kristen Boehmer of Empowered Lyfe Partners with MD Logic Health to Launch Daily Colostrum, an Advanced Low Molecular Weight Bioactive Colostrum
09/03/2026 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
09/03/2026 -
Transactions in Connection with Share Buy-back Program
09/03/2026 -
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education
09/03/2026 -
CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
09/03/2026 -
Zealand Pharma to participate in upcoming investor conferences in March 2026
09/03/2026 -
Surgery Partners, Inc. to Present at Upcoming Investor Conference
09/03/2026 -
Hydration Room Opens in San Francisco’s Cow Hollow, Introducing Nurse-Administered, Medically Supervised IV Therapy Designed for Sustained Performance and Recovery
09/03/2026 -
Valneva publiera ses résultats financiers consolidés 2025 le 18 mars 2026
09/03/2026
Pages